Cochrane · systematic review · CD003223
Calcitonin for metastatic bone pain
Martinez-Zapata, MJ, Roqué i Figuls, M, Català, E, et al. · Cochrane Database of Systematic Reviews · 2006 · Cochrane Library
Pain, Palliative and Supportive CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings
Population: Patients withmetastatic bone pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Complete pain relief | RR 2.5 [0.55, 11.41] | 1 study · 40 participants | Very low Downgraded: imprecision |
Less or equal analgesia consumption | RR 1.05 [0.9, 1.21] | 1 study · 48 participants | Very low Downgraded: risk of bias, imprecision |
Adverse effects | RR 3.5 [0.77, 15.88] | 2 studies · 88 participants | Very low Downgraded: risk of bias, imprecision |